Distinguishing clinical and imaging characteristics of primary central nervous system lymphoma from high-grade glioma and metastatic brain tumors
Clinical and Translational Oncology · 2024
DOI: 10.1007/s12094-024-03771-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Qian Hu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma, Central Nervous System Neoplasms, Lymphoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Science Foundation of Suqian, Suqian Key Laboratory of Hematology, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
OBJECTIVE: The purpose of this retrospective analysis was to evaluate the clinical presentations, radiological characteristics, patient outcomes, and therapeutic approaches among individuals diagnosed with primary central nervous system lymphoma (PCNSL), high-grade glioma (HGG), and metastatic brain tumors (METS). METHODS: We assembled a cohort of brain tumor patients from two medical centers, with two oncologists independently reviewing their clinical profiles. A retrospective examination of 87 PCNSL, 87 HGG, and 71 METS cases was performed to assess the aforementioned parameters. RESULTS: Notable variations were identified in the incidence of epileptic seizures and cognitive impairments between PCNSL and METS patients. Cerebral hemisphere involvement was predominantly observed in HGG and METS cases. PCNSL cases exhibited a higher likelihood of multiple lesions, whereas HGG showed a greater tendency for recurrence. The median survival times were established at 24.3 months for PCNSL, 44.5 months for HGG, and 27.1 months for METS patients. In PCNSL cases, the number of lesions was identified as a significant predictor of mortality (P = 0.008). CONCLUSIONS: Our findings highlight the importance of clinical and imaging features in diagnosing PCNSL, which may present distinct features compared to HGG and METS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
- Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
- Department of General Practice and Emergency Medicine, B.P. Koirala Institute of Health Sciences, Sunsari, Nepal.
- Department of Medical Record Statistics, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
- Department of Radiology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
- Department of Neurology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China. haochen-2008@hotmail.com.
Förderung
- Science Foundation of Suqian
- Suqian Key Laboratory of Hematology
- Natural Science Foundation of Jiangsu Province
- Development Fund of Affiliated Hospital of Xuzhou Medical University
Zitieren
APA
Hu, Q., Zhang, S., Ma, R. X., Lu, F., Zhang, Q., Jing, J., Raza, H. K., Li, S., Cheng, L., Zhang, Z., He, L., Meng, W., Chen, H., & Chen, W. (2024). Distinguishing clinical and imaging characteristics of primary central nervous system lymphoma from high-grade glioma and metastatic brain tumors. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03771-3
Vancouver
Hu Q, Zhang S, Ma RX, Lu F, Zhang Q, Jing J, et al. Distinguishing clinical and imaging characteristics of primary central nervous system lymphoma from high-grade glioma and metastatic brain tumors. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03771-3
BibTeX
@article{Hu2024,
author = {Hu, Qian and Zhang, Shenyang and Ma, Rui Xue and Lu, Fengyi and Zhang, Qi and Jing, Jia and Raza, Hafiz Khuram and Li, Shengli and Cheng, Li and Zhang, Zuohui and He, Lin and Meng, Wenqing and Chen, Hao and Chen, Wei},
title = {Distinguishing clinical and imaging characteristics of primary central nervous system lymphoma from high-grade glioma and metastatic brain tumors},
journal = {Clinical and Translational Oncology},
year = {2024},
doi = {10.1007/s12094-024-03771-3}
}
EUVIMED